The government has waived Custom on Remdesivir, Beta Cyclodextrin (SBEBCD) used in the manufacture of Remdesivir as well as Remdesivir injections.
The Centre on Tuesday has waived Custom on Remdesivir Remdesivir, its raw materials, and other components used to make the antiviral drug until 31 October amid a surge in COVID-19 cases in the country. The government has waived customs duty on Remdesivir active pharmaceutical ingredients (APIs), injection Remdesivir, and beta Cyclodextrin used in the manufacture of Remdesivir, the finance ministry said in a statement.
The move would help augment domestic availability and reduce cost of the injection. Remdesivir is being used in the treatment of coronavirus.
Author’s Take on waiver of Custom on Remdesivir
This is a very good step by the Central Government as the manufacturing of this medicine done by Indian Company “Cipla“, very expensive to the consumers. Waiving import duty might give relief for the consumers and Indian manufacturers might also reduce the price to tackle competition.
Commerce and Industry Minister Piyush Goyal tweeted
“In line with PM @NarendraModi’s priority to ensure affordable medical care for COVID-19 patients, imports of Remdesivir API, injection and specific inputs have been made import duty free. This should increase supply and reduce cost thus providing relief to patients.”
Earlier this month, the Centre banned export of the injection and its APIs till the situation improves.
Seducing the Price of Medicines of Remdesivir
The National Pharmaceutical Pricing Authority (NPPA) had last week said various drug companies had cut the prices of Remdesivir injection on the intervention of the government. Cadila Healthcare has reduced the price of its REMDAC (Remdesivir 100 mg) injection to ₹899 from ₹2,800. Similarly, Syngene International has cut the price of its brand RemWin to ₹2,450 from ₹3,950.
In an address to the nation, Prime Minister Narendra Modi also called upon all stakeholders, including the pharmaceutical industry, to deal collectively with the immediate challenge of the shortage of oxygen cylinders.
The country is fighting a very big battle against the pandemic, he said, adding that its second wave has hit it like a storm after the condition appeared to have stabilized.